TOKYO--(BUSINESS WIRE)--Cegedim Relationship Management today announced that Kyowa Pharmaceutical Industry Co., Ltd. has implemented Mobile Intelligence, the innovative Customer Relationship Management (CRM) solution designed exclusively for the Life Sciences industry. Kyowa selected the solution to boost the effectiveness of its sales force - promoting optimal interactions between sales representatives and Japan’s healthcare professionals (HCPs). Headquartered in Osaka, Kyowa Pharmaceutical is a member of the Lupin Group of India, and focuses its product portfolio on high-quality generics catered to psychiatric and neurological therapies.
Japan’s rapidly aging population is prompting the government to enact austerity measures that include a reliance on generic medications. This positions generic manufacturers for dynamic growth, and Kyowa is taking advantage of this opportunity. One of Kyowa’s tactics for enhancing commercial effectiveness during this critical time is to leverage a game-changing CRM optimized for the Life Sciences.
“Cegedim has a strong track record in CRM solutions for the Japanese pharmaceutical industry, and provides standardized templates based on proven expertise. Therefore, we evaluated that Cegedim’s solutions provide the necessary and sufficient functions for us,” said Mr. Noriaki Tsunoda, President and Representative Director, Kyowa Pharmaceutical Industry Co., Ltd. “Also, it was an important part of our decision that the Cegedim implementation team has extensive knowledge about the pharmaceutical industry. Cegedim understands our sales strategy well, and with their tablet offering and cloud-based architecture, we have the flexibility and security to empower our sales force with on-the-go accessibility. We are confident that the system will be an intelligent infrastructure. Furthermore, we can accelerate intelligence sharing between the sales force and the back-office. We expect that this will bring our organization agility (as our slogan “One Team”), and will help us take full advantage of business opportunities. We believe Mobile Intelligence will become our indispensable key weapon for our growth strategy. Although market transformation and tough competition will happen in the future, we expect that Cegedim will continue to provide leading solutions for generic pharmaceutical companies, and help them improve.”
“It’s inspiring to help Kyowa capitalize on this unique growth opportunity. Mobile Intelligence empowers the enterprise to elevate efficiency, not only for members of commercial teams, but also back-end divisions that are enabled with the ability to enhance governance and strategy execution,” said Stefan Janssens, President EMEA & APAC, Cegedim Relationship Management. “Building on their 60-year legacy in the Life Sciences, we’re expecting to propel Kyowa on a path of continued prosperity with our innovative, next generation CRM.”
Cegedim Relationship Management is the Life Sciences industry’s leading provider of Customer Relationship Management (CRM) solutions. Designed specifically for Life Sciences, the company’s innovative business solutions incorporate a thorough understanding of local, regional and worldwide trends. Cegedim Relationship Management enables approximately 200,000 users in many of the world’s most innovative companies to stay ahead of market challenges. In addition to CRM, Cegedim Relationship Management also provides marketing, data optimization and regulatory compliance solutions in more than 80 countries. Cegedim Relationship Management is part of the France-based Cegedim S.A. Group.
To learn more, please visit: www.CegedimRM.com.
Founded in 1969, Cegedim is a global technology and services
company specializing in the healthcare field. Cegedim supplies
services, technological tools, specialized software, data flow
management services and databases. Its offerings are targeted
notably at healthcare industries, life sciences companies,
healthcare professionals and insurance companies. The world leader
in life sciences CRM, Cegedim is also one of the leading suppliers
of strategic healthcare industry data. Cegedim employs 8,000
people in more than 80 countries and generated revenue of €902
million in 2013. Cegedim SA is listed in Paris (EURONEXT: CGM).
Follow Cegedim on Twitter: @CegedimGroup.